Retatrutide is a novel triple receptor agonist peptide that targets the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R)
Both medications can cause gastrointestinal side effects, especially when starting or increasing dose
Supplements containing vitamins such as Vitamin A, Vitamin C, and Vitamin E, as well as minerals like zinc and selenium, can support skin health
Patients experiencing unintentional weight loss beyond expected therapeutic effects , fever, or night sweats alongside digestive symptoms should seek medical assessment, as these may suggest conditions unrelated to semaglutide
Indications 1.Type 2 Diabetes Mellitus (T2DM) As an adjunct to diet and exercise to improve glycemic control in adults